ABVC BioPharma appoints Hsin-Hui Miao to board after director's passing

ABVC BIOPHARMA, INC.

Director Dr. Shin-Yu Miao passed away; vacancy filled by his sister Hsin-Hui Miao.
Ms. Miao appointed on June 4, 2022, effective immediately, serving until next annual meeting.
She will join Audit, Corporate Governance & Nomination, and Compensation committees.
Ms. Miao receives $3,500 monthly compensation, same as other directors.
No related-party transactions above $120,000 or 1% of assets in last two years.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Hsin-Hui Miao

Director

ABVC · ABVC BIOPHARMA, INC.

Effective: 2022-06-04
Successor: Dr. Shin-Yu Miao
Filed: June 9, 2022, 7:59 PM ET

the board appointed Ms. Hsin-Hui Miao to fill the vacancy created by Dr. Miao’s passing.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hsin-Hui Miao was appointed as Director at ABVC BIOPHARMA, INC..

Action: appointed
Role: Director

Exact text from the filing

the board appointed Ms. Hsin-Hui Miao to fill the vacancy created by Dr. Miao’s passing.

View on SEC.gov

ABVC BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001213900-22-031976

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.